SORAS Group Limited

Graphite for North America Graphex Group Receives Unsolicited Preliminary Offer and LOI to Buy Graphex Technologies and Propel its North American Expansion Strategy

Retrieved on:

Wednesday, December 6, 2023

The consideration for the Acquisition will be paid by the Purchaser solely in shares of its common stock (“Consideration Shares”).

Key Points:

The consideration for the Acquisition will be paid by the Purchaser solely in shares of its common stock (“Consideration Shares”).
The final consideration will be determined in the definitive agreement to be entered into by both parties after further negotiations.
However, there can be no assurance that the Acquisition will be completed on acceptable terms or at all.
As soon as practicable upon the completion of the Acquisition, Graphex Group intends to distribute the Consideration Shares to all its shareholders on a pro rata basis.

Aptorum Group Enters into Letter of Intent and Term Sheet To Acquire U Group

Retrieved on:

Monday, March 27, 2023

Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Company”), today announced that it entered into a non-binding Letter of Intent and Term Sheet (“Term Sheet”) for the acquisition (“Transaction”) of 100% of URF Holding Group Limited and its underlying businesses (collectively “U Group”) by the further issuance of the Company’s class A ordinary shares as consideration.

Key Points:

Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Company”), today announced that it entered into a non-binding Letter of Intent and Term Sheet (“Term Sheet”) for the acquisition (“Transaction”) of 100% of URF Holding Group Limited and its underlying businesses (collectively “U Group”) by the further issuance of the Company’s class A ordinary shares as consideration.
U Group’s business strategy, based on the urban revitalization force philosophy, includes the development of curated shopping experience targeting China’s “Generation Z” consumption growth through implementing concepts such as “Curetail” (curated retail) in commercial premises and rejuvenating community neighbourhoods.
Pursuant to the Term Sheet, the Transaction will result in a reverse takeover of the Company and, subject to the below matters and conditions, including continued listing of the combined entity on Nasdaq.
The relevant Term Sheet has been filed under a 6-K by the Company.

Aptorum Group Limited to Hold Special Extraordinary Meeting of Shareholders on February 21, 2023

Retrieved on:

Monday, February 6, 2023

Biotechnology, Infectious Diseases, Health, Pharmaceutical, Oncology, Central European Time, SORAS Group Limited, Form 6-K, Electric Bond and Share Company v. Securities and Exchange Commission, Infection, Euronext Paris, Nightclub, Security (finance)

Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Aptorum”), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune diseases and infectious diseases, today announced that it will hold a special extraordinary meeting of shareholders at the London office 4T.07, 17 Hanover Square, Mayfair London, England W1S 1BN at 10:00 a.m. London Time on February 21, 2023 (5:00 a.m. Eastern Standard Time on February 21, 2023 / 10:00 a.m. Greenwich Mean Time on February 21, 2023 / 11:00 a.m. Central European Time on February 21, 2023).

Key Points:

Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Aptorum”), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune diseases and infectious diseases, today announced that it will hold a special extraordinary meeting of shareholders at the London office 4T.07, 17 Hanover Square, Mayfair London, England W1S 1BN at 10:00 a.m. London Time on February 21, 2023 (5:00 a.m. Eastern Standard Time on February 21, 2023 / 10:00 a.m. Greenwich Mean Time on February 21, 2023 / 11:00 a.m. Central European Time on February 21, 2023).
The proposals to be submitted for shareholders’ approval at the special extraordinary meeting are to consider and vote on the resolutions for a merger of the Company with a newly established wholly owned subsidiary whereby the Company would be the surviving company in order to change the par value of the Company shares from USD10 to USD0.00001, and certain amendments of the Company’s Second Amended and Restated Memorandum and Articles of Association.
Details related to each of the two proposals are available on a Form 6-K filed with the U.S. Securities and Exchange Commission on February 6, 2023.

Genius Group to Hold Extraordinary General Meeting on February 16

Retrieved on:

Wednesday, January 25, 2023

Education, Technology, Software, Other Education, Networks, Continuing, Internet, Transfer, Share repurchase, EGM, SORAS Group Limited, Cyprus Securities and Exchange Commission, URL, NYSE, Computer, Person, Tablet, Form 6-K, Security (finance)

Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading entrepreneur edtech and education group, will hold an extraordinary general meeting of shareholders (the “EGM”) on February 16, 2023, at 8:00 a.m.

Key Points:

Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading entrepreneur edtech and education group, will hold an extraordinary general meeting of shareholders (the “EGM”) on February 16, 2023, at 8:00 a.m.
The proposals to be submitted for shareholders' approval at the EGM are to consider and vote on the resolutions for a share repurchase mandate and a share consolidation.
Details related to each of the two proposals are available on a Form 6-K filed with the U.S. Securities and Exchange Commission on January 25, 2023.
The EGM will be held as a digital meeting only, with no in-person attendance for shareholders.

Genius Group Announced the Initial Results of Its Shares Market Activity Investigation

Retrieved on:

Wednesday, January 4, 2023

Software, Networks, Internet, Other Education, Continuing, Technology, Education, Mobile, Wireless, Initial, SORAS Group Limited, NYSE, LLP, Pharmaceutical industry

Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading entrepreneur edtech and education group, announces today that the Initial results of the investigation made by Christian Levine Law Group and Warshaw Burstein, LLP, indicates that certain individuals and/or companies appear to have sold (but not delivered) a significant amount of the stock of the company, which is illegal and appears to be part of a market manipulation scheme seeking to artificially depress the price of the securities of the company.

Key Points:

Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading entrepreneur edtech and education group, announces today that the Initial results of the investigation made by Christian Levine Law Group and Warshaw Burstein, LLP, indicates that certain individuals and/or companies appear to have sold (but not delivered) a significant amount of the stock of the company, which is illegal and appears to be part of a market manipulation scheme seeking to artificially depress the price of the securities of the company.
The company will continue to investigate who is responsible for manipulating its share price and will aggressively pursue all remedies against any and all parties responsible for damaging the company.

Genius Group to Organize Virtual Investor Meeting with CEO Roger Hamilton

Retrieved on:

Friday, December 30, 2022

Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading entrepreneur edtech and education group, announces that it will organize a virtual investor meeting on Tuesday, January 10, 2022, with its Chief Executive Officer, Roger Hamilton to provide an update on the business and its subsidiaries and respond to shareholder enquiries.

Key Points:

Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading entrepreneur edtech and education group, announces that it will organize a virtual investor meeting on Tuesday, January 10, 2022, with its Chief Executive Officer, Roger Hamilton to provide an update on the business and its subsidiaries and respond to shareholder enquiries.
To ensure all enquiries are answered, all shareholder questions need to be submitted in advance to the email address [email protected] .
Webcast: Go to the Investor Relations section of the Genius Group website to register to the webcast.

Aptorum Group Limited Announces Results of 2022 Annual General Meeting of Shareholders

Retrieved on:

Thursday, December 22, 2022

Research, Infectious Diseases, Clinical Trials, Biotechnology, General Health, Pharmaceutical, Health, Science, Oncology, Other Science, Euronext Paris, SORAS Group Limited, Infection, Degenerative disease, LLP, Effective date, Remuneration, Holding company

Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Aptorum”), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune diseases and infectious diseases, announced the results of its 2022 annual general meeting of shareholders, which was held on December 21, 2022, in London.

Key Points:

Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Aptorum”), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune diseases and infectious diseases, announced the results of its 2022 annual general meeting of shareholders, which was held on December 21, 2022, in London.
At the annual general meeting, the required number of shareholders of the Company:
Re-elected all seven directors to hold office until the next annual meeting of shareholders or until their respective successors are elected and duly qualified;
Approved, ratified and confirmed the re-appointment of Marcum Asia CPAs LLP (formerly known as Marcum Bernstein & Pinchuck LLP) as the Company’s independent auditors for the year ending December 31, 2022 and authorized the Board of Directors to fix the remuneration of the auditors; and
Approved that every 10 Class A Ordinary Shares of a par value of US$1.00 per share in the authorized share capital of the Company (including issued and unissued share capital) be consolidated into 1 Class A Ordinary Share of a par value of US$10.00 per share; and that every 10 Class B Ordinary Share of a par value of US $1.00 per share in the authorized share capital of the Company (including issued and unissued share capital) be consolidated into 1 Class B Ordinary Share of a par of US$10.00 per share (the “Share Consolidation” or “Reverse Stock Split”), such that immediately following the Share Consolidation, the authorized share capital of the Company will be US$100,000,000.00 divided into 6,000,000 Class A Ordinary Shares with a nominal or par value of US$10.00 each and 4,000,000 Class B Ordinary Shares with a nominal or par value of US$10.00 each; with such Share Consolidation to be effective on any date on or prior to December 21, 2023 as determined by the Board of Directors (the “Effective Date”); and the Effective Date when determined by the Board of Directors shall be announced by the Company.
In the event that no Effective Date has been determined by the Board of Directors, the share capital of the Company shall remain unchanged unless otherwise resolved by the shareholders of the Company; and the authority granted to the Board of Directors in this proposal will terminate and no Share Consolidation will be implemented.

Wejo and Ford Team Up to Expand End-to-End Insurance Offerings Across U.S.

Retrieved on:

Tuesday, November 29, 2022

Insurance providers will be able to better understand driving behaviors through connected vehicle data and insights to support user-based intelligence for end-to-end insurance with the help of Wejo and Fords collaboration.

Key Points:

Insurance providers will be able to better understand driving behaviors through connected vehicle data and insights to support user-based intelligence for end-to-end insurance with the help of Wejo and Fords collaboration.
This announcement comes after Wejo and Ford successfully launched the same program throughout Europe in June .
Our expanded partnership with Ford for end-to-end insurance is a significant step toward reinventing auto insurance for a smarter, safer future.
We are excited to expand our insurance data services relationship with Wejo into the U.S. market, said Amy Graham, Services Marketing director at Ford Motor Company.

New Analyst Report on Genius Group from Zachs Small Cap Research With a Target Price of $19.20

Retrieved on:

Monday, September 26, 2022

Education, Technology, Other Education, Apps, Applications, Curriculum, Student, Leadership, SORAS Group Limited, NYSE, Educational technology, Medicine

Genius Group Limited (Genius Group or the Company) (NYSE American: GNS), announces that Zachs Small Cap Research published a new analyst report on Genius Group on Wednesday, September 21, 2022 with a target price of $19.20.

Key Points:

Genius Group Limited (Genius Group or the Company) (NYSE American: GNS), announces that Zachs Small Cap Research published a new analyst report on Genius Group on Wednesday, September 21, 2022 with a target price of $19.20.
Genius Group is a world leading entrepreneur Edtech and education group, with a mission to disrupt the current education model with a student-centered, life-long learning curriculum that prepares students with the leadership, entrepreneurial and life skills to succeed in todays market.
The group has over 2.9 million students in 200 countries, ranging from ages 0 to 100.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220926005280/en/

Genius Group acquires California based University of Antelope Valley

Retrieved on:

Monday, July 11, 2022

Genius Group Limited (Genius Group or the Company) (NYSE American: GNS), a world-leading entrepreneur Edtech and education group, is pleased to announce the acquisition of the USA-based University of Antelope Valley (UAV).

Key Points:

Genius Group Limited (Genius Group or the Company) (NYSE American: GNS), a world-leading entrepreneur Edtech and education group, is pleased to announce the acquisition of the USA-based University of Antelope Valley (UAV).
Following its IPO on NYSE American on April 12, 2022, Genius Group is now integrating its IPO Acquisitions into its Genius Curriculum.
As part of Genius Group, the university will now be able to achieve their mission at a global scale.
Founders of UAV Marco and Sandra Johnson, commented:
We are so excited about the additional resources, students and faculty members that Genius Group can bring to University of Antelope Valley.